Acute bronchospasm from the patient's perspective: Role of patient education

Pharmacotherapy

Volumn 26, Issue 9 II, 2006, Pages

  Williams, Dennis ^a  

^a UNIVERSITY OF NORTH CAROLINA   (United States)

Author keywords

Asthma; Chronic obstructive pulmonary disease; COPD; DPI; Dry powder inhaler; Global Asthma Physician and Patient Survey; MDI; Metered dose inhaler; Nebulizers; Peak expiratory flow; Spacer or holding chamber devices

Indexed keywords

BETA ADRENERGIC RECEPTOR STIMULATING AGENT; LEVALBUTEROL; SALBUTAMOL;

ASTHMA; BRONCHOSPASM; CAREGIVER; CHRONIC OBSTRUCTIVE LUNG DISEASE; CONFERENCE PAPER; DISEASE EXACERBATION; DRUG DELIVERY SYSTEM; DRUG EFFICACY; EXERCISE TOLERANCE; HEALTH STATUS; HUMAN; LUNG FUNCTION; MEDICAL NEBULIZER; METERED DOSE INHALER; MORTALITY; PATIENT COMPLIANCE; PATIENT EDUCATION; PEAK EXPIRATORY FLOW; PHYSICIAN; POWDER INHALER; QUALITY OF LIFE;

ASTHMA; BRONCHIAL SPASM; BRONCHODILATOR AGENTS; HUMANS; NEBULIZERS AND VAPORIZERS; PATIENT EDUCATION; PATIENT EDUCATION AS TOPIC; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE;

EID: 33748098381     PISSN: 02770008     EISSN: None     Source Type: Journal    
DOI: 10.1592/phco.26.9part2.193S     Document Type: Conference Paper

References (12)

1. National Heart, Lung, and Blood Institutes. Morbidity and mortality: 2004 chartbook on cardiovascular, lung, and blood diseases. Bethesda, MD: U.S. Department of Health and Human Services, National Institutes of Health, 2004:1-89.
2. National Heart, Lung, and Blood Institute, National Asthma Education and Prevention Program. Practical guide for the diagnosis and management of asthma. NIH publication no. 97-4053. Bethesda, MD: U.S. Department of Health and Human Services, National Institutes of Health, October 1997.
3. World Allergy Organization and American College of Asthma, Allergy and Immunology. Global asthma physician and patient survey. Available from http://www.gappsurvey.org. Accessed March 21, 2006.
4. GlaxoSmithKline. Asthma in America: a landmark survey. Available from http://www.asthmainamerica.com. Accessed February 6, 2006.
5. White MV, Sanders N. Asthma from the perspective of the patient. J Allergy Clin Immonol 1999;104(2 pt 2):S47-52.
6. Berger WE, Ames DE, Harrison D. A patient satisfaction survey comparing levalbuterol-with racemic albuterol in children. Allergy Asthma Proc 2004;25:437-44.
7. National Heart, Lung, and Blood Institute, and World Health Organization. Global strategy for the diagnosis, management, and prevention of chronic obstructive lung disease, updated 2005. Global initiative for chronic obstructive lung disease. Bethesda, MD: National Institutes of Health, 2005:1-128.
8. Dolovich MB, Ahrens RC, Hess DR, et al. Device selection and outcomes of aerosol therapy: evidenced-based guidelines: American College of Chest Physicians/American College of Asthma, Allergy, and Immunology. Chest 2005;127:335-71.
9. Interiano B, Guntupalli KK. Metered-dose inhalers. Do health care providers know what to teach? Arch Intern Med 1993;153:81-5.
10. Hanania NA, Wittman R, Kesten S, Chapman KR. Medical personnel's knowledge of and ability to use inhaling devices: metered-dose inhalers, spacing chambers, and breath-actuated dry powder inhalers. Chest 1994;105:111-16.
11. Kesten S, Zive K, Chapman KR. Pharmacist knowledge and ability to use inhaled medication delivery systems. Chest 1993;104:1648-9.
12. Cain WT, Cable G, Oppenheimer JJ. The ability of the community pharmacist to learn the proper actuation techniques of inhaler devices. J Allergy Clin Immunol 2001;108:918-20.